nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute rejection after liver transplantation is less common, but predicts better prognosis in HBV-related hepatocellular carcinoma patients
|
Mao, Jia-Xi |
|
|
14 |
3 |
p. 347-361 |
artikel |
2 |
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort
|
Quaranta, Maria Giovanna |
|
|
14 |
3 |
p. 362-372 |
artikel |
3 |
Adverse outcomes of proton pump inhibitors in chronic liver disease: a systematic review and meta-analysis
|
Wang, Junna |
|
|
14 |
3 |
p. 385-398 |
artikel |
4 |
Antibiotics for prophylaxis of spontaneous bacterial peritonitis: systematic review & Bayesian network meta-analysis
|
Soni, Hariom |
|
|
14 |
3 |
p. 399-413 |
artikel |
5 |
Comparison of HBsAg changes between HBeAg-negative patients who discontinued or maintained entecavir therapy
|
Chen, Chien-Hung |
|
|
14 |
3 |
p. 317-325 |
artikel |
6 |
Efficacy of oral antiviral drugs to prevent mother-to-child transmission of hepatitis B virus: a network meta-analysis
|
Jia, Fang |
|
|
14 |
3 |
p. 338-346 |
artikel |
7 |
Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management
|
Lee, Way S. |
|
|
14 |
3 |
p. 305-316 |
artikel |
8 |
Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer
|
Chen, Wei |
|
|
14 |
3 |
p. 326-337 |
artikel |
9 |
Proton pump inhibitors in chronic liver disease: accomplice or bystander?
|
Mak, Lung-Yi |
|
|
14 |
3 |
p. 299-301 |
artikel |
10 |
Stopping oral antiviral treatment to cure chronic hepatitis B, is it in sight?
|
Fan, Rong |
|
|
14 |
3 |
p. 302-304 |
artikel |
11 |
Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma
|
Huge, Nicole |
|
|
14 |
3 |
p. 373-384 |
artikel |